Serum protein profile alterations in hemodialysis patients

American Journal of Nephrology

Volumn 24, Issue 2, 2004, Pages 268-274

  Langlois, Richard G ^a   Trebes, James E ^a   Dalmasso, Enrique A ^b   Ying, Yong ^b   Davies, Robert W ^c   Curzi, Mario P ^c   Colston Jr , Bill W ^a   Turteltaub, Kenneth W ^a   Perkins, Julie ^a   Chromy, Brett A ^a   Choi, Megan W ^a   Murphy, Gloria A ^a   Fitch, J Patrick ^a   McCutchen Maloney, Sandra L ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

^c Diablo Nephrology Medical Group   (United States)

Author keywords

Biomarkers; Hemodialysis; Protein profiling; Proteomics; SELDI TOF MS

Indexed keywords

METAL; PLASMA PROTEIN; PROTEOME;

ANALYTIC METHOD; ANION EXCHANGE; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CASE REPORT; CATION EXCHANGE; CHEMISTRY; CONTROLLED STUDY; DESORPTION; DISEASE COURSE; EVALUATION; FEMALE; HEALTH STATUS; HEMODIALYSIS; HUMAN; HYDROPHOBICITY; IONIZATION; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; SERUM; SURFACE PROPERTY; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; BLOOD PROTEINS; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 11144357674     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077409     Document Type: Article

References (15)

1. Tyers M, Mann M: From genomics to proteomics. Nature 2003;422:193-197.
2. Hanash S: Disease proteomics. Nature 2003;422:226-232.
3. Anderson NL, Anderson NG: The human plasma proteome. Mol Cell Proteomics 2002;1:845-867.
4. Kennedy S: Proteomic profiling from human samples: The body fluid alternative. 2001;120:379-384.
5. Hutchens TW, Yip TT: New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-580.
6. Issaq HJ, Conrads TP, Prieto AP, Tirumalai R, Veenstra TD: SELDI-TOF-MS for diagnostic proteomics. Anal Chem 2003;149A-155A.
7. Paweletz CP, Liotta LA, Petricoin EF: New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology 2001;57:160-163.
8. Vlahou A, Schellhammer PF, Medrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright GL Jr: Development of a novel approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-1501.
9. Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS: Discovery of distinct protein profiles specific for lung tumors and premalignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003;40:267-279.
10. Wulfkuhle JD, McLean KC, Pawaletz CP, Sgroi DC, Trock BJ, Steeg PS, Petricoin EF III: New approaches to proteomic analysis of breast cancer. Proteomics 2001;1:1205-1215.
11. Petricoin EF III, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.
12. Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser DF, Sanchez JC: A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003;3:1486-1494.
13. Clark W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP: Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003;237:660-665.
14. Issaq HJ, Veenstra TD, Conrads TP, Felschow D: The SELDI-TOF-MS approach to proteomics: Protein profiling and biomarker identification. Biochem Biophys Res Commun 2002;292:587-592.
15. Poon TCW, Yip TT, Chan ATC, Yip C, Yip V, Mok TSK, Lee CCY, Leung TWT, Ho SKW, Johnson PJ: Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-760.